Close Menu

Pathway Genomics' Insight test will be on the shelves of about 6,000 Walgreens, reports the Washington Post. This "boldest move yet to bring the power of modern molecular medicine to the mass market" may also me "irresponsible" as it "could give many buyers a dangerous false sense of security or, conversely, needlessly alarm them," the Post says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.